Social Europe

politics, economy and employment & labour

  • Projects
    • Corporate Taxation in a Globalised Era
    • US Election 2020
    • The Transformation of Work
    • The Coronavirus Crisis and the Welfare State
    • Just Transition
    • Artificial intelligence, work and society
    • What is inequality?
    • Europe 2025
    • The Crisis Of Globalisation
  • Audiovisual
    • Audio Podcast
    • Video Podcasts
    • Social Europe Talk Videos
  • Publications
    • Books
    • Dossiers
    • Occasional Papers
    • Research Essays
    • Brexit Paper Series
  • Shop
  • Membership
  • Ads
  • Newsletter

The false scarcity of vaccine trade tensions

by Katie Gallogly-Swan on 8th February 2021 @GalloglySwan

Share on TwitterShare on FacebookShare on LinkedIn

The row over the EU introducing vaccine export controls has occluded its rejection of a temporary waiver on intellectual property rights.

intellectual property rights,private patents
Katie Gallogly-Swan

As we approach the anniversary of the pandemic’s declaration by the World Health Organization, health and care systems around the world are being rocked by a second wave of cases, dwarfing the first surge last spring.

In the initial stages of the pandemic, the fear of the impact on national populations led to more than 100 export controls around the world for crucial medicines and medical equipment. Understandably, governments moved to protect their own citizens but the lack of co-ordination resulted in an inefficient distribution of these vital supplies, hindering global capacity to stem surges at their root.

Responding to such trade controls within the European Union, the European Commission president, Ursula von der Leyen, told the European Parliament last March that ‘a crisis without borders cannot be resolved by putting barriers between us’.

Against this experience, the commission’s announcement on January 29th of new export controls on vaccines surprised many around the world—drawing criticism from key allies, the WHO and indeed von der Leyen’s predecessor, Jean-Claude Juncker. While the commission put this down to a breach of contract obligations, the resounding impression given was of putting European citizens first in the scramble to secure vaccines, when the global nature of the pandemic meant nation-first approaches were doomed to fail.

Waiver blocked

Yet the idea that the EU was prioritising access for its own citizens was itself flawed, since alongside wealthy individual states, such as the United States, the United Kingdom, Japan and Australia, it continues to block a temporary waiver on intellectual property rights for Covid-19 vaccines, which is backed by most members of the World Trade Organization. Such a waiver would make the patents, industrial designs and trade secrets used to make Covid-19 vaccines global public goods—meaning more vaccines to distribute at less cost to public coffers around the world.

Join our growing community newsletter!

"Social Europe publishes thought-provoking articles on the big political and economic issues of our time analysed from a European viewpoint. Indispensable reading!"

Polly Toynbee

Columnist for The Guardian

Thank you very much for your interest! Now please check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

Powered by ConvertKit

UNICEF figures reveal that only 43 per cent of reported Covid-19 vaccine production capacity is currently being used for the approved vaccines. According to the People’s Vaccine campaign, the three biggest manufacturers in the world are only producing vaccines for about 1.5 per cent of the global population—much less than their total capacity if patents did not stand in the way.

Last week, the Danish company Bavarian Nordic offered to manufacture up to 240 million vaccines in its newly-built facilities but this offer is yet to be taken up by any of the major vaccine companies. While wealthy countries have bought up most of the first stocks of viable vaccine candidates, there is also untapped production potential across different regions, with 20 more vaccine manufacturers in India alone.

Private patents

At the current rate of vaccination, it will take seven years for enough of the world to be vaccinated to prevent further transmission. Seven years is a long time for the virus to mutate and build resistance to currently viable vaccinations—a risk recently highlighted by the emergence of new strains. With the looming risk of reinfection with a more deadly or contagious version of the virus, it is paramount that every tool at our disposal is oriented to producing enough vaccines to eradicate it swiftly everywhere.

Artificial rationing is what is driving vaccine nationalism, yet the EU again blocked the waiver at the Trade Related Intellectual Property Rights Council meeting at the WTO last Thursday, claiming that private patents were needed to encourage innovation. As others have pointed out, however, much of the industry’s innovation has been predicated on decades of public support for research and development. Indeed, governments around the world have invested €88.3 billion in Covid-19 vaccine development so far.


We need your help! Please join our mission to improve public policy debates.


As you may know, Social Europe is an independent publisher. We aren't backed by a large publishing house or big advertising partners. For the longevity of Social Europe we depend on our loyal readers - we depend on you. You can support us by becoming a Social Europe member for less than 5 Euro per month.

Thank you very much for your support!

Become a Social Europe Member

For citizens of countries with the fiscal space to support such investments, this amounts to paying for the vaccine three times: when their government supported vaccine development, when it bought stocks and when it funds the COVAX facility intended to secure vaccines for poorer countries pushed out of the race. While the EU and other wealthy regions have borne the brunt of the public-health challenge, with the vast majority of cases and deaths, a recent study has found that failing to vaccinate people in low-income countries will have the worst economic impact on wealthy economies.

Unleash production

A waiver on intellectual property would see a drastic decrease in the cost of vaccination for all governments, with more regional production unleashed across the world. This is not simply a case of high-income countries versus low-income but of patent monopolies, propped up by a few WTO members, versus the safety of everyone.

The EU and others blocking the waiver have chosen to back these pharmaceutical-company monopolies over their own public health and any hope of a rapid, global vaccination programme. The same companies shunned the voluntary Covid-19 Technology Access Pool launched by the WHO early in the pandemic—the head of Pfizer calling the initiative ‘nonsense’—while making billions in profit from Covid-19 vaccines.

Keeping the patents of Covid-19 vaccines secret offers no demonstrable public benefit to the global pandemic effort. Instead, it is leading to chauvinistic policy choices which erode co-operation and trust and prolong the pandemic for everyone.

Share on TwitterShare on FacebookShare on LinkedIn
Home ・ Society ・ The false scarcity of vaccine trade tensions

Filed Under: Most popular, Society

About Katie Gallogly-Swan

Katie Gallogly-Swan is policy co-ordinator for the joint project on a Global Green New Deal between the United Nations Conference on Trade and Development and the Global Development Policy Center at Boston University. She sits on the board of the Scottish Women’s Budget Group and has previously worked at Oxfam and ActionAid.

Partner Ads

Most Popular Posts

Thomas Piketty,capital Capital and ideology: interview with Thomas Piketty Thomas Piketty
sovereignty Brexit and the misunderstanding of sovereignty Peter Verovšek
China,cold war The first global event in the history of humankind Branko Milanovic
centre-left, Democratic Party The Biden victory and the future of the centre-left EJ Dionne Jr
Covid 19 vaccine Designing vaccines for people, not profits Mariana Mazzucato, Henry Lishi Li and Els Torreele

Most Recent Posts

supply chain,Germany,human rights Germany’s proposed supply-chain law—a glass half-empty Johanna Kusch and Claudia Saller
Myanmar,due diligence Human-rights due diligence and Myanmar Frank Hoffer
women workers,services Covid-19: a tale of two service sectors John Hurley
Uber,drivers,gig UK gig drivers recognised as workers—what next? Jill Toh
European Pillar of Social Rights,social pillar EU credibility as a people’s union rests on the social pillar Liina Carr

Other Social Europe Publications

RE No. 12: Why No Economic Democracy in Sweden?
US election 2020
Corporate taxation in a globalised era
The transformation of work
The coronavirus crisis and the welfare state

Social Europe Publishing book

With a pandemic raging, for those countries most affected by Brexit the end of the transition could not come at a worse time. Yet, might the UK's withdrawal be a blessing in disguise? With its biggest veto player gone, might the European Pillar of Social Rights take centre stage? This book brings together leading experts in European politics and policy to examine social citizenship rights across the European continent in the wake of Brexit. Will member states see an enhanced social Europe or a race to the bottom?

'This book correctly emphasises the need to place the future of social rights in Europe front and centre in the post-Brexit debate, to move on from the economistic bias that has obscured our vision of a progressive social Europe.' Michael D Higgins, president of Ireland


MORE INFO

Hans Böckler Stiftung Advertisement

Renewing labour relations in the German meat industry: an end to 'organised irresponsibility'?

Over the course of 2020, repeated outbreaks of Covid-19 in a number of large German meat-processing plants led to renewed public concern about the longstanding labour abuses in this industry. New legislation providing for enhanced inspection on health and safety, together with a ban on contract work and limitations on the use of temporary agency employees, holds out the prospect of a profound change in employment practices and labour relations in the meat industry. Changes in the law are not sufficient, on their own, to ensure decent working conditions, however. There is also a need to re-establish the previously high level of collective-bargaining coverage in the industry, underpinned by an industry-wide collective agreement extended by law to cover the entire sector.


FREE DOWNLOAD

ETUI advertisement

ETUI/ETUC (online) conference Towards a new socio-ecological contract 3-5 February 2021

The need to effectively tackle global warming puts under pressure the existing industrial relations models in Europe. A viable world of labour requires a new sustainability paradigm: economic, social and environmental.

The required paradigm shift implies large-scale economic and societal change and serious deliberation. All workers need to be actively involved and nobody should be left behind. Massive societal coalitions will have to be built for a shared vision to emerge and for a just transition, with fairly distributed costs, to be supported. But this is also an opportunity to redefine our societal goals and how they relate to the current focus on (green) growth.


REPLAY ALL SESSIONS

To access the videos, click on the chosen day then click on the ‘video’ button of your chosen session (plenary or panel). It will bring you immediately to the corresponding video. To access the available presentations, click on the chosen day then click on the ‘information’ button. Check the links to the available presentations.

Eurofound advertisement

Industrial relations: developments 2015-2019

Eurofound has monitored and analysed developments in industrial relations systems at EU level and in EU member states for over 40 years. This new flagship report provides an overview of developments in industrial relations and social dialogue in the years immediately prior to the Covid-19 outbreak. Findings are placed in the context of the key developments in EU policy affecting employment, working conditions and social policy, and linked to the work done by social partners—as well as public authorities—at European and national levels.


CLICK FOR MORE INFO

Foundation for European Progressive Studies Advertisement

FEPS Progressive Yearbook

Twenty-twenty has been an extraordinary year. The Covid-19 pandemic and the multidimensional crisis that it triggered have boosted existing trends and put forward new challenges. But they have also created unexpected opportunities to set a new course of action for the European Union and—hopefully—make a remarkable leap forward in European integration.

The second edition of the Progressive Yearbook, the yearly publication of the Foundation for European Progressive studies, revolves around the exceptional events of 2020 and looks at the social, economic and political impact they will have in 2021. It is a unique publication, which aims to be an instrument for the progressive family to reflect on the recent past and look ahead to our next future.


CLICK HERE

About Social Europe

Our Mission

Article Submission

Legal Disclosure

Privacy Policy

Copyright

Social Europe ISSN 2628-7641

Find Social Europe Content

Search Social Europe

Project Archive

Politics Archive

Economy Archive

Society Archive

Ecology Archive

.EU Web Awards